Feverfew Willow Magnesium Supplement for Migraine Prophylaxis
Solution Overview
Problem
Current treatments for migraines, particularly those involving pharmaceutical drugs, often lead to chronification and lack effectiveness in prophylactic measures, while alternative remedies like feverfew and white willow extracts show promise but require confirmation and combination with other agents to address cerebral stress and anxiety.
Innovation Solution
The association of dry extracts of feverfew and white willow with magnesium, administered orally in specific ratios and forms, provides an adjuvant treatment and prevention for primary headaches such as migraine with and without aura, tension, and chronic headaches, reducing relapses, pain, and cerebral stress.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pharmaceutical drugs are used to treat migraines, then acute pain relief is achieved, but chronification and lack of prophylactic effectiveness occur
Solution Approach 1:
The patent combines three distinct substances (feverfew extract, white willow extract, and magnesium) into a single synergistic formulation. This merging of multiple therapeutic agents addresses both the prophylactic need and pain relief requirement while avoiding the chronification issue associated with single-drug pharmaceutical treatments.
Solution Approach 2:
The invention creates a composite therapeutic formulation integrating plant extracts and mineral supplements. This composite approach leverages the complementary mechanisms of action of each component: feverfew for migraine prevention, white willow for pain relief, and magnesium for neurological stabilization, achieving both prophylaxis and treatment without harmful side effects.
2Reliability
If alternative remedies like feverfew and white willow extracts are used, then promise for reducing migraine symptoms is shown, but effectiveness requires confirmation and combination with other agents
Solution Approach 1:
The patent merges feverfew extract, white willow extract, and magnesium into a unified formulation. This combination addresses the limitation of individual alternative remedies by creating a synergistic effect where each component enhances the overall therapeutic outcome, providing both symptom reduction and addressing underlying causes.
Solution Approach 2:
The invention formulates a composite preparation that integrates multiple natural substances. This composite approach confirms and enhances the effectiveness of individual alternative remedies by combining them with complementary agents, creating a more reliable and comprehensive treatment than any single substance alone.
3Object-generated harmful factors
If current treatments address only acute phases, then pain control is achieved, but underlying causes like cerebral stress and anxiety are not addressed
Solution Approach 1:
The patent creates a multi-functional formulation where the same combination of substances addresses multiple aspects of migraine: feverfew for prophylaxis, white willow for acute pain, and magnesium for neurological stabilization and stress reduction. This universal formulation simultaneously treats symptoms and addresses underlying causes without requiring separate therapies.
Solution Approach 2:
The invention merges prophylactic, analgesic, and neuro-stabilizing functions into a single formulation. By combining substances with complementary mechanisms of action, the treatment addresses both acute pain control and underlying cerebral stress and anxiety, providing a comprehensive approach that current monotherapies cannot achieve.
Data Source
AI summary
Association of dry extract of feverfew, dry extract of willow and magnesium for use as an adjuvant in the prophylaxis and treatment of migraine and related oral compositions, in particular as a food supplement.